Document:

<PAGE>

                                                                    EXHIBIT 10.2

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE
LAWS, AND NO INTEREST THEREIN MAY BE SOLD, DISTRIBUTED, ASSIGNED, OFFERED,
PLEDGED OR OTHERWISE TRANSFERRED UNLESS THERE IS AN EFFECTIVE REGISTRATION
STATEMENT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS COVERING ANY SUCH
TRANSACTION OR SUCH TRANSACTION IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF
SUCH ACT AND LAWS, SUCH COMPLIANCE, AT THE OPTION OF THE CORPORATION, TO BE
EVIDENCED BY AN OPINION OF WARRANTHOLDER'S COUNSEL, IN FORM ACCEPTABLE TO THE;
CORPORATION, THAT NO VIOLATION OF SUCH REGISTRATION PROVISIONS WOULD RESULT FROM
ANY PROPOSED TRANSFER OR ASSIGNMENT.

                    SERIES "P" COMMON STOCK PURCHASE WARRANT

                        BIOJECT MEDICAL TECHNOLOGIES INC.

       THIS CERTIFIES that for good and valuable consideration received, Elan
International Services, Ltd., or registered assigns, is entitled, upon the terms
and subject to the conditions hereinafter set forth, to acquire from Bioject
Medical Technologies Inc., an Oregon corporation (the "Corporation") up to
3,790,000 fully paid and nonassessable shares of common stock, without par
value, of the Corporation ("Warrant Stock") at a purchase price per share (the
"Exercise Price") of $1.50.

1.     TERM OF WARRANT

       Subject to the terms and conditions set forth herein, this Warrant shall
be exercisable, in whole or from time to time part, at any time on or after the
date hereof and at or prior to 11:59 p.m., Pacific Standard Time, on June 30,
2006 (the "Expiration Time"). Notwithstanding the foregoing, the holder hereof
shall exercise this Warrant (by payment of the applicable Exercise Price (in
cash or by cancellation of indebtedness of the Corporation to the holder hereof
as provided in Section 2 of this Warrant)), (i) on the Effective Date (as
defined in the Agreement among the Company and Elan Pharmaceutical Investments,
Ltd. and Elan International Services, Ltd. dated December 12, 2001 (the
"Agreement")) for 252,666 shares of the Warrant Stock, (ii) within 30 days of
the holder's receipt of written notice from the Corporation that on the first
anniversary of the Effective Date the Market Price (as defined below) of common
stock of the Corporation (the "Common Stock") was at least $12.50 per share
(such notice to include evidence reasonably satisfactory to the holder hereof as
to the basis for the calculation of such price and to be given no later than the
fifth business day following such anniversary and in such manner as is specified
in Section 9 of the Agreement), for 252,667 shares of the Warrant Stock and
(iii) within 30 days of the holder's receipt of written notice from the
Corporation that on the second anniversary of the Effective Date the Market
Price of the Common Stock was at least $15.00 per share (such notice to include
evidence reasonably satisfactory to the holder hereof as to the basis for the
calculation of such price and to be given no later than the fifth business day
following such anniversary and in such manner as is specified in Section 9 of
the Agreement), for the remaining Warrant Stock not previously purchased
pursuant to an exercise of this Warrant; provided, however, the holder hereof is
not obligated to make any such exercise unless at such time at least one or more
registration statements is then effective pursuant to which all the Warrant
Stock issued or issuable upon exercise hereof may be publicly sold by such
holder under the Securities Act of 1933, as amended; provided, further, however,
that notwithstanding the foregoing provisions of this sentence, the holder of
this Warrant retains the right to exercise this Warrant at any time pursuant to
the first sentence of this Section 1. In the event that the holder hereof has
not exercised this Warrant for all Warrant Stock as of the close of business on
the later of (x) the fifth business day after the second anniversary of the
Effective Date if no notice pursuant to clause (iii) above has been delivered to
the holder hereof on or before such date or (y) the 30th day following receipt
by the holder hereof of any notice pursuant to clause (iii) above, as a result
of the failure of the conditions set forth in the immediately preceding
sentence, then thereafter the provisions of such sentence shall terminate and
have no further force or effect. All share amounts and prices per share in this
Section 1 shall be subject to appropriate adjustment from time to time pursuant
to Section 11 of this Warrant.

                                      -1-
<PAGE>

       "Market Price" means, with respect to each anniversary of the Effective
Date requiring a calculation thereof as provided above, the average of the daily
Closing Prices (as defined below) per share of the Common Stock for the 10
consecutive trading days ending on the trading day immediately preceding such
anniversary; provided, however, that in the event that the Market Price is
determined during a period following the announcement by the Corporation of (A)
a dividend or distribution of Common Stock, or (B) any subdivision, combination
or reclassification of Common Stock and prior to the expiration of 20 business
days after the ex-dividend date for such dividend or distribution, or the record
date for such subdivision, combination or reclassification, then, and in each
such case, the Market Price shall be appropriately adjusted to reflect the
current market price per share equivalent of the Common Stock. "Closing Price"
means the reported last sales price regular way or, if no such reported sale
occurs on such day, the average of the closing bid and asked prices regular way
on such day, in each case as re-ported by NASDAQ or such other principal
consolidated transaction reporting system with respect to securities listed on
the principal national securities exchange on which the Common Stock is listed
or admitted to trading, or any comparable system then in use or, if not so
re-ported, as reported by any New York Stock Exchange member firm reasonably
selected by the holder of this Warrant for purposes of establishing whether this
Warrant must be exercised pursuant to the second sentence of this Section 1.

2.     EXERCISE OF WARRANT

       The purchase rights represented by this Warrant are exercisable by the
registered holder hereof, in whole or in part, at any time and from time to time
at or prior to the Expiration Time by the surrender of this Warrant and the
Notice of Exercise form attached hereto duly executed to the office of the
Corporation at 7620 S.W. Bridgeport Road, Portland, Oregon 97224 (or such other
office or agency of the Corporation as it may designate by notice in writing to
the registered holder hereof at the address of such holder appearing on the
books of the Corporation), and upon payment of the Exercise Price for the shares
thereby purchased (by cash or by check or bank draft payable to the order of the
Corporation or by cancellation of indebtedness of the Corporation to the holder
hereof, if any, at the time of exercise in an amount equal to the purchase price
of the shares thereby purchased); whereupon the holder of this Warrant shall be
entitled to receive from the Corporation a stock certificate in proper form
representing the number of shares of Warrant Stock so purchased

3.     ISSUANCE OF SHARES; NO FRACTIONAL SHARES OF SCRIP

       Certificates for shares purchased hereunder shall be delivered to the
holder hereof by the Corporation's transfer agent at the Corporation's expense
within a reasonable time after the date on which this Warrant shall have been
exercised in accordance with the terms hereof. Each certificate so delivered
shall be in such denominations as may be requested by the holder hereof and
shall be registered in the name of such holder or, subject to applicable laws,
other name as shall be requested by such holder. If, upon exercise of this
Warrant, fewer than all of the shares of Warrant Stock evidenced by this Warrant
are purchased prior to the Expiration Time, one or more new warrants
substantially in the form of, and on the terms in, this Warrant will be issued
for the remaining number of shares of Warrant Stock not purchased upon exercise
of this Warrant. The Corporation hereby represents and warrants that all shares
of Warrant Stock which may be issued upon the exercise of this Warrant will,
upon such exercise, be duly and validly authorized and issued, fully paid and
nonassessable and free from all taxes, liens and charges in respect of the
issuance thereof (other than liens or charges created by or imposed upon the
holder of the Warrant Stock). The Corporation agrees that the shares so issued
shall be and be deemed to be issued to such holder as the record owner of such
shares as of the close of business on the date on which this Warrant shall have
been surrendered for exercise in accordance with the terms hereof. No fractional
shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. With respect to any fraction of a share called for upon the
exercise of this Warrant, an amount equal to such fraction multiplied by the
then current price at which each share may be purchased hereunder shall be paid
in cash to the holder of this Warrant.

4.     CHARGES, TAXES AND EXPENSES

       Issuance of certificates for shares of Warrant Stock upon the exercise of
this Warrant shall be made without charge to the holder hereof for any issue or
transfer tax or other incidental expense in respect of the issuance of such
certificate, all of which taxes and expenses shall be paid by the Corporation,
and such certificates shall be issued in the name of the holder of this Warrant
or in such name or names as may be directed by the holder of this Warrant;
provided, however, that in the event certificates for shares of Warrant Stock
are to be issued in a name other than the

                                      -2-
<PAGE>

name of the holder of this Warrant, this Warrant when surrendered for exercise
shall be accompanied by the Assignment Form attached hereto duly executed by the
holder hereof.

5.     NO RIGHTS AS SHAREHOLDERS

       This Warrant does not entitle the holder hereof to any voting rights or
other rights as a shareholder of the Corporation prior to the exercise hereof.

6.     EXCHANGE AND REGISTRY OF WARRANT

       This Warrant is exchangeable, upon the surrender hereof by the registered
holder at the above-mentioned office or agency of the Corporation, for a new
Warrant of like tenor and dated as of such exchange. The Corporation shall
maintain at the above-mentioned office or agency a registry showing the name and
address of the registered holder of this Warrant. This Warrant may be
surrendered for exchange, transfer or exercise, in accordance with its terms, at
such office or agency of the Corporation, and the Corporation shall be entitled
to rely in all respects, prior to written notice to the contrary, upon such
registry.

7.     LOSS, THEFT, DESTRUCTION OR MUTILATION OF WARRANT

       Upon receipt by the Corporation of evidence reasonably satisfactory to it
of the loss, theft, destruction or mutilation of this Warrant, and in case of
loss, theft or destruction of indemnity or security reasonably satisfactory to
it, and upon reimbursement to the Corporation of all reasonable expenses
incidental thereto, and upon surrender and cancellation of this Warrant, if
mutilated, the Corporation will make and deliver a new Warrant of like tenor and
dated as of such cancellation, in lieu of this Warrant.

8.     SATURDAYS, SUNDAYS AND HOLIDAYS

       If the last or appointed day for the taking of any action or the
expiration of any right required or granted herein shall be a Saturday or a
Sunday or shall be a legal holiday, then such action may be taken or such right
may be exercised on the next succeeding day not a Saturday, Sunday or legal
holiday.

9.     MERGER, SALE OF ASSETS, ETC.

       If at any time the Corporation proposes to merge or consolidate with or
into any other corporation, effect any reorganization, or sell or convey all or
substantially all of its assets to any other entity, then, as a condition of
such reorganization, consolidation, merger, sale or conveyance, the Corporation
or its successor, as the case may be, shall enter into a supplemental agreement
to make lawful and adequate provision whereby the holder shall have the right to
receive, upon exercise of the Warrant, the kind and amount of equity securities
which would have been received upon such reorganization, consolidation, merger,
sale or conveyance by a holder of a number of shares of common stock equal to
the number of shares issuable upon exercise of the Warrant immediately prior to
such reorganization, consolidation, merger, sale or conveyance. If the property
to be received upon such reorganization, consolidation, merger, sale or
conveyance is not equity securities, the Corporation shall give the holder of
this Warrant ten (10) business days prior written notice of the proposed
effective date of such transaction, and if this Warrant has not been exercised
by or on the effective date of such transaction, it shall terminate.

10.    SUBDIVISION, COMBINATION, RECLASSIFICATION, CONVERSION, ETC.

       If the Corporation at any time shall, by subdivision, combination,
reclassification of securities or otherwise, change the Warrant Stock into the
same or a different number of securities of any class or classes, this Warrant
shall thereafter entitle the holder to acquire such number and kind of
securities as would have been issuable in respect of the Warrant Stock (or other
securities which were subject to the purchase rights under this Warrant
immediately prior to such subdivision, combination, reclassification or other
change) as the result of such change if this Warrant had been exercised in full
for cash immediately prior to such change. The Exercise Price hereunder shall be
adjusted if and to the extent necessary to reflect such change. If the Warrant
Stock or other securities issuable upon exercise hereof are subdivided or
combined into a greater or smaller number of shares of such security, the number

                                      -3-
<PAGE>

of shares issuable hereunder shall be proportionately increased or decreased, as
the case may be, and the Exercise Price shall be proportionately reduced or
increased, as the case may be, in both cases according to the ratio which the
total number of shares of such security to be outstanding immediately after such
even bears to the total number of shares of such security outstanding
immediately prior to such event. The Corporation shall give the holder prompt
written notice of any change in the type of securities issuable hereunder, any
adjustment of the Exercise Price for the securities issuable hereunder, and any
increase or decrease in the number of shares issuable hereunder.

11.    TRANSFERABILITY; COMPLIANCE WITH SECURITIES LAWS

       (a) This Warrant may not be transferred or assigned in whole or in part
without compliance with all applicable federal and state securities laws by the
transferor and transferee (including the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Corporation, if
requested by the Corporation). Subject such restrictions, prior to the
Expiration Time, this Warrant and all rights hereunder are transferable by the
holder hereof, in whole or in part, at the office or agency of the Corporation
referred to in Section 1 hereof. Any such transfer shall be made in person or by
the holder's duly authorized attorney, upon surrender of this Warrant together
with the Assignment Form attached hereto properly endorsed.

       (b) The Holder of this Warrant, by acceptance hereof, acknowledges that
this Warrant and the Warrant Stock issuable upon exercise hereof are being
acquired solely for the holder's own account and not as a nominee for any other
party, and for investment, and that the holder will not offer, sell or otherwise
dispose of this Warrant or any shares of Warrant Stock to be issued upon
exercise hereof except under circumstances that will not result in a violation
of the Securities Act of 1933, as amended, or any state securities laws. Upon
exercise of this Warrant, the holder shall, if requested by the Corporation,
confirm in writing, in a form satisfactory to the Corporation, that the shares
of Warrant Stock so purchased are being acquired solely for holder's own account
and not as a nominee for any other party, for investment, and not with a view
toward distribution or resale.

       (c) The Warrant Stock has not been and will not be registered under the
Securities Act of 1933, as amended, and this Warrant may not be exercised except
by (i) the original purchaser of this Warrant from the Corporation or (ii) an
"accredited investor" as defined in Rule 501(a) under the Securities Act of
1933, as amended. Each certificate representing the Warrant Stock or other
securities issued in respect of the Warrant Stock upon any stock split, stock
dividend, recapitalization, merger, consolidation or similar event, shall be
stamped or otherwise imprinted with a legend substantially in the following form
(in addition to any legend required under applicable securities laws):

       THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER UNITED
STATES FEDERAL OR STATE SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD OR
OTHERWISE TRANSFERRED OR ASSIGNED FOR VALUE, DIRECTLY OR INDIRECTLY, NOR MAY THE
SECURITIES BE TRANSFERRED ON THE BOOKS OF THE CORPORATION, WITHOUT REGISTRATION
OF SUCH SECURITIES UNDER ALL APPLICABLE UNITED STATES FEDERAL OR STATE
SECURITIES LAWS OR COMPLIANCE WITH AN APPLICABLE EXEMPTION THEREFROM, SUCH
COMPLIANCE, AT THE OPTION OF THE CORPORATION, TO BE EVIDENCED BY AN OPINION OF
SHAREHOLDER'S COUNSEL, IN FORM ACCEPTABLE TO THE CORPORATION, THAT NO VIOLATION
OF SUCH REGISTRATION PROVISIONS WOULD RESULT FROM ANY PROPOSED TRANSFER OR
ASSIGNMENT.

12.    REPRESENTATIONS AND WARRANTIES

       The Corporation hereby represents and warrants to the holder hereof that:

       (a) during the period this Warrant is outstanding, the Corporation will
reserve from its authorized and unissued common stock a sufficient number of
shares to provide for the issuance of Warrant Stock upon the exercise of this
Warrant;

                                      -4-
<PAGE>

       (b) the issuance of this Warrant shall constitute full authority to the
Corporation's officers who are charged with the duty of executing stock
certificates to execute and issue the necessary certificates for the shares of
Warrant Stock issuable upon exercise of this Warrant;

       (c) the Corporation has all requisite legal and corporate power to
execute and deliver this Warrant, to sell and issue the Warrant Stock hereunder,
to issue the common stock issuable upon exercise of the Warrant Stock and to
carry out and perform its obligations under the teens of this Warrant;

       (d) all corporate action on the part of the Corporation, its directors
and shareholders necessary for the authorization, execution, delivery and
performance of this Warrant by the Corporation, the authorization, sale,
issuance and delivery of the Warrant Stock, the grant of registration rights as
provided herein and the performance of the Corporation's obligations hereunder
has been taken;

       (e) the Warrant Stock, when issued in compliance with the provisions of
this Warrant and the Corporation's Articles of Incorporation (as they may be
amended from time to time (the "Articles")), will be validly issued, fully paid
and nonassessable, and free of all taxes, liens or encumbrances with respect to
the issue thereof, and will be issued in compliance with all applicable federal
and state securities laws; and

       (f) the issuance of the Warrant Stock will not be subject to any
preemptive rights, rights of first refusal or similar rights.

13.    CORPORATION

       The Corporation will not, by amendment of its Articles or through any
reorganization, recapitalization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other action, avoid or seek to
avoid the observance or performance of any of the terms to be observed or
performed hereunder by the Corporation, but will at all times in good faith
assist in the carrying out of all the provisions of this Warrant and in the
taking of all such action as may be necessary or appropriate in order to protect
the rights of the holder of the Warrant against impairment.

14.    GOVERNING LAW

       This Warrant shall be governed by and construed in accordance with the
laws of the State of Oregon.

       IN WITNESS WHEREOF, the Corporation has caused this Warrant to be
executed by its duly authorized officers.

Dated: _________________________,  2002

BIOJECT MEDICAL TECHNOLOGIES INC.

By:
   -----------------------------------------
Name:
Title:

                                      -5-Exhibit 10.21

           AMENDMENT NO. 1 AND CONSENT TO LOAN AND SECURITY AGREEMENT

                                                              November 2, 2001

Congress Financial Corporation (Southern)
200 Galleria Parkway, Suite 1500
Atlanta, Georgia 30339

   Re:  Loan and Security Agreement, dated October 11, 2000

Ladies and Gentlemen:

     Congress  Financial  Corporation  (Southern)  ("Lender")  and Galion,  Inc.
("Galion"),  Valentec  Wells,  LLC,  formerly  known as  Valentec  International
Corporation,  LLC  ("Valentec"),  Safety Components  Fabric  Technologies,  Inc.
("SCFT"),   Automotive  Safety  Components   International,   Inc.  ("Automotive
International"),  Automotive  Safety  Components  International  GmbH  & Co.  KG
("German  Borrower"),  Automotive Safety Components  International  Limited ("UK
Borrower" and together with Galion, Valentec, SCFT, Automotive International and
German Borrower, individually each a "Borrower" and collectively,  "Borrowers"),
Safety Components  International,  Inc. ("Safety"),  ASCI Holdings Germany (DE),
Inc. ("ASCI Germany"),  ASCI Holdings U.K. (DE), Inc. ("ASCI UK"), ASCI Holdings
Mexico (DE),  Inc.  ("ASCI  Mexico"),  ASCI  Holdings  Czech (DE),  Inc.  ("ASCI
Czech"),  Automotive Safety Components International,  S.A. de C.V. ("Automotive
Safety  Mexico")  and  Automotive   Safety   Components   International   s.r.o.
("Automotive Safety Czech" and together with Safety, ASCI Germany, ASCI UK, ASCI
Mexico, ASCI Czech and Automotive Safety Mexico, each individually a "Guarantor"
and  collectively,   "Guarantors")  have  entered  into  financing  arrangements
pursuant to which  Lender has made and may make loans and  advances to Borrowers
as set forth in the Loan and Security Agreement,  dated October 11, 2000, by and
among Lender,  Borrowers and Guarantors (as the same now exists or may hereafter
be amended, modified, supplemented, extended, renewed, restated or replaced, the
"Loan  Agreement") and other agreements,  documents and instruments  referred to
therein or at any time  executed  and/or  delivered in  connection  therewith or
related thereto,  together with this Amendment (all of the foregoing,  including
the Loan Agreement, as the same now exist or may hereafter be amended, modified,
supplemented,  extended,  renewed,  restated  or  replaced,  being  collectively
referred to herein as the "Financing  Agreements").  All capitalized  terms used
herein shall have the meaning  assigned  thereto in the Loan  Agreement,  unless
otherwise defined herein.

     UK Borrower has advised Lender that it has entered into an Agreement, dated
November 2, 2001 (the "TISPP  Purchase  Agreement"),  by and between UK Borrower
and TISPP UK Limited (the "Seller"),  pursuant to which the Seller has agreed to
sell, and UK Borrower has agreed to acquire, the Seller's automotive  inflatable
airbag business (the "TISPP Acquired Assets") presently conducted at Cadley Hill
Industrial Estate, Swadlincote,  Derbyshire,  England (the "TISPP Premises") for
an aggregate purchase price of 3,000,000 pounds sterling,  all as more fully set
forth in the TISPP Purchase Agreement.

     Borrowers and Guarantors have requested that Lender agree to amend the Loan
Agreement  as set forth below,  and Lender is willing to agree to such  requests
subject to the terms and conditions contained herein.

<PAGE>

     In consideration of the forgoing and the agreements and covenants contained
herein,  and for  other  good  and  valuable  consideration,  the  adequacy  and
sufficiency  of which are  hereby  acknowledged,  the  parties  hereto  agree as
follows:

1. Amendments

     (a)  Definitions.

          (i) Additional Definitions. Section 1 of the Loan Agreement is hereby
     amended by adding the following definitions in their proper alphabetical
     order:

               "TISPP" shall mean TISPP UK Limited, a company incorporated under
          the laws of England and Wales with company number 446036.

               "TISPP Acquired Assets" shall mean the assets sold by TISPP to UK
          Borrower as set forth on Schedule 1 hereto.

               "TISPP  Purchase  Agreement"  shall  mean  the  Agreement,  dated
          November 2, 2001,  by and between UK Borrower  and TISPP,  as the same
          may be amended, supplemented or otherwise modified from time to time.

               "TISPP  Purchase   Documents"   shall  mean  the  TISPP  Purchase
          Agreement  and all  documents,  agreements  and  instruments  executed
          and/or delivered in connection therewith or relating thereto.

          (ii)  Amendment to Definition of Eligible  Inventory.  Section 1.35 of
     the Loan  Agreement  is hereby  amended  by  adding  the  following  clause
     immediately before the period at the end of the second sentence thereof:

               "; and (r) any  finished  goods which bear or  otherwise  utilize
          (and any raw  materials  which  will bear or  otherwise  utilize)  the
          "Woodville" trade name or any derivation thereof."

     (b)  Encumbrances.  Section 9.8 of the Loan  Agreement is hereby amended by
(a) deleting  the period at the end of clause (j) thereof and  replacing it with
"; and" and (b) adding at the end of such Section a new clause (k) as follows:

          "(k)  liens and  security  interests  of TISPP on the  TISPP  Acquired
     Assets to secure the  Indebtedness  of UK Borrower  permitted under Section
     9.9(h)."

     (c)  Indebtedness.  Section 9.9 of the Loan  Agreement is hereby amended by
(a) deleting  the period at the end of clause (g) thereof and  replacing it with
"; and" and (b) adding at the end of such Section a new clause (h) as follows:

          "(h)  Indebtedness  of UK  Borrower to TISPP  evidenced  by or arising
     under  the TISPP  Purchase  Agreement  (as in  effect on the date  hereof);
     provided, that:

               (i) the principal  amount of such  Indebtedness  shall not exceed
          2,000,000   pounds   sterling,   less  the  aggregate  amount  of  all
          repayments,  repurchases or redemptions  thereof,  whether optional or
          mandatory, and no interest thereon shall be payable,

               (ii) Borrowers and Guarantor  shall not,  directly or indirectly,
          make any  payments  in respect of such  Indebtedness,  except  that UK
          Borrower may make regularly  scheduled  payments of principal when due
          in accordance  with the terms of the TISPP  Purchase  Agreement (as in
          effect on the date hereof),

               (iii)  Lender  shall have  received  true,  correct and  complete
          copies of the TISPP  Purchase  Agreement and the other  material TISPP
          Purchase  Documents,  duly  executed  and  delivered  by  the  parties
          thereto,

               (iv) Borrowers and Guarantor  shall not,  directly or indirectly,
          (A)  amend,  modify,  alter  or  change  any  of  the  terms  of  such
          Indebtedness or any of the TISPP Purchase  Documents,  except that, UK
          Borrower may,  after prior written  notice to Lender,  amend,  modify,
          alter or change the terms thereof so as to extend the maturity thereof
          or defer the timing of any payments in respect thereof,  or to forgive
          or cancel any  portion of such  Indebtedness  other than  pursuant  to
          payments  thereof,  or  (B)  redeem,  retire,  defease,   purchase  or
          otherwise acquire such Indebtedness, or set aside or otherwise deposit
          or invest any sums for such  purpose,  except for  payments  expressly
          permitted by Section 9.9(h)(ii), and

                                       2
<PAGE>

               (v) Borrowers and Guarantors  shall furnish to Lender all notices
          or demands in connection with such  Indebtedness  either received by a
          Borrower  or  Guarantor  or on its behalf  promptly  after the receipt
          thereof,  or  sent  by a  Borrower  or  Guarantor  or  on  its  behalf
          concurrently with the sending thereof, as the case may be."

          (d) Loans,  Investments,  Guarantees,  Etc.  Section  9.10 of the Loan
     Agreement is hereby amended by (a) deleting the period at the end of clause
     (p) thereof and replacing it with "; and" and (b) adding at the end of such
     Section and new clause (q) as follows:

               "(q) the  acquisition by UK Borrower of the TISPP Acquired Assets
          in accordance  with the terms of the TISPP  Purchase  Agreement (as in
          effect on the date hereof); provided, that:

                    (i) the  aggregate  amount of the purchase  price payable in
               respect of the TISPP Acquired  Assets shall not exceed  3,000,000
               pounds sterling, not more than 1,000,000 pounds sterling of which
               shall be payable at the closing of such acquisition;

                    (ii) Borrowers and Guarantors and their Subsidiaries,  other
               than UK Borrower,  shall not be directly or indirectly liable (by
               virtue of such  Borrower or  Guarantor  or  Subsidiary  being the
               primary obligor on, guarantor of, or otherwise liable) in respect
               of any  amounts  from time to time owing  under or in  connection
               with the TISPP Purchase Documents;

                    (iii) none of the TISPP Acquired Assets shall be included in
               the Borrowing Base of any Borrower; and

                    (iv) the  occurrence  of a default with respect to the TISPP
               Purchase  Documents  shall not result in, or permit any holder of
               any Indebtedness of any Borrower or Guarantor or Subsidiary owing
               to any Person  (other  than  TISPP) to  declare,  a default  with
               respect to such  Indebtedness  or cause the payment thereof to be
               accelerated or payable prior to its stated maturity.

2.  Consents.   Subject  to  the  terms  and  conditions  contained  herein  and
notwithstanding  anything  to the  contrary  contained  in the  Loan  Agreement,
including  without  limitation  Section 9.12  thereof,  and the other  Financing
Agreements,  Lender hereby consents to (a) the sale by UK Borrower to Automotive
Safety  Czech,  Automotive  Safety  Germany or a newly  formed (or to be formed)
Romanian Subsidiary of Safety (the "Romanian  Subsidiary") of the portion of the
TISPP Acquired Assets  consisting of Equipment (the "TISPP Acquired  Equipment")
in consideration of Indebtedness from Automotive Safety Czech, Automotive Safety
Germany or the Romanian Subsidiary,  as the case may be, to UK Borrower, and (b)
the  relocation  of the TISPP  Acquired  Equipment  to a  location  in the Czech
Republic,   Romania,  United  Kingdom  or  Germany;  provided,  that,  (i)  such
Indebtedness shall not be evidenced by a promissory note or other instrument and
(ii) on the  date of such  sale or  relocation,  no  Event  of  Default  or act,
condition or event which with notice or passage of time or both would constitute
an Event of Default, shall exist or have occurred and be continuing.

3.  Representations,  Warranties  and  Covenants.  Each Borrower and  Guarantor,
jointly and severally,  represents, warrants and covenants with and to Lender as
follows,  which  representations,  warranties  and covenants are  continuing and
shall survive the execution and delivery  hereof,  the truth and accuracy of, or
compliance  with  each,  together  with  the  representations,   warranties  and
covenants in the other Financing Agreements, being a continuing condition of the
making or providing of any Loans or Letter of Credit Accommodations by Lender to
Borrowers:

     (a)  neither  the  execution  and  delivery  of this  Amendment,  the TISPP
Purchase  Agreement or the  documents,  agreements  or  instruments  executed or
delivered in connection  therewith or related  thereto  (collectively,  with the
TISPP Purchase Agreement, the "TISPP Purchase Documents"),  nor the consummation
of the  transactions  herein or therein  contemplated,  nor compliance  with the
provisions  hereof or thereof are in  contravention  of any law or regulation or
any  order or  decree  of any  court or  Governmental  Authority  applicable  to
Borrowers or Guarantors or any of their respective  Subsidiaries in any respect,
or  conflict  with or result in the breach of, or  constitutes  a default in any
respect  under any mortgage,  deed of trust,  security  agreement,  agreement or
instrument  to which any Borrower or  Guarantor  is a party or may be bound,  or
violates any provision of the  Certificate  of  Incorporation  or By-Laws of any
Borrower or Guarantor; and

                                       3
<PAGE>

     (b) no Event of Default or act,  condition  or event  which with  notice or
passage  or time or both would  constitute  an Event of  Default,  exists or has
occurred and is continuing.

4. Conditions Precedent. The amendments and consent set forth herein shall be
effective upon the satisfaction of each of the following conditions precedent in
a manner satisfactory to Lender:

     (a) the receipt by Lender of an original of this Amendment, duly
authorized, executed and delivered by Borrowers and Guarantors;

     (b) the  receipt by Lender of the TISPP  Purchase  Agreement  and the other
material TISPP Purchase Documents  (including,  without limitation,  the chattel
mortgage,  the deed of postponement,  the transition  services agreement and the
underlease  agreement),  duly authorized,  executed and delivered by the parties
thereto, which shall be in form and substance satisfactory to Lender;

     (c) the receipt by Lender of evidence (including,  without limitation,  any
discharge or release of any liens of security  interests  in the TISPP  Acquired
Assets),  in form and substance  satisfactory  to Lender,  that (i) Lender holds
valid,  perfected  fixed  charges,  security  interests  and  liens on the TISPP
Acquired Assets,  superior in priority to all other charges,  security interests
and  liens  in  favor  of all  Persons  except  for the  Seller,  (ii)  all lien
registrations  relating to the TISPP  Acquired  Assets in favor of Lender  shall
have been duly filed and recorded  and (iii) all  certificates  of  registration
have  been  filed  with  respect  to the TISPP  Acquired  Assets  consisting  of
intellectual property;

     (d) the  receipt  by Lender of: (i) a  collateral  assignment  of the TISPP
Purchase Documents,  duly authorized,  executed and delivered by UK Borrower and
acknowledged by the Seller,  in form and substance  satisfactory to Lender,  and
(ii) a supplemental equipment mortgage, duly authorized,  executed and delivered
by UK Borrower, in form and substance satisfactory to Lender;

     (e) all requisite  corporate action and proceedings in connection with this
Amendment  shall be  satisfactory  in form and  substance to Lender,  and Lender
shall have  received  all  information  and copies of all  documents,  including
records of  requisite  corporate  action and  proceedings  which Lender may have
requested in connection  therewith,  such documents where requested by Lender or
its counsel to be certified by appropriate  corporate  officers or  governmental
authorities; and

     (f) the  receipt  by Lender of such  reports as to the  Collateral  and the
lending  formulas of each  Borrower as Lender shall  reasonably  request,  which
shall be presented on a pro forma basis after giving effect to the  transactions
contemplated by the TISPP Purchase Documents.

5. General.

     (a) Effect of this Amendment. Except as expressly provided herein, no other
changes or  modifications  to the Financing  Agreements are intended or implied,
and in all other  respects  the  Financing  Agreements  are hereby  specifically
ratified, restated and confirmed by all parties hereto as of the date hereof. To
the extent any  conflict  exists  between  the terms of this  Amendment  and the
Financing Agreements, the terms of this Amendment shall control.

     (b)  Governing  Law.  The rights and  obligations  hereunder of each of the
parties hereto shall be governed by and interpreted and determined in accordance
with the  internal  laws of the  State of New York  (without  giving  effect  to
principles  of  conflicts of laws or other rules of law that would result in the
application of the law of any jurisdiction other than the State of New York).

                                       4
<PAGE>

     (c) Binding  Effect.  This Amendment is binding upon and shall inure to the
benefit of Lender,  Borrowers,  Guarantors and their  respective  successors and
assigns.  Any  amendment or consent  contained  herein shall not be construed to
constitute  an amendment or consent to any other or further  action by Borrowers
or  Guarantors or to entitle  Borrowers or Guarantors to any other  amendment or
consent.  The Loan Agreement and this  Amendment  shall be read and construed as
one agreement.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       5

<PAGE>

     (d)  Counterparts,  etc.  This  Amendment  may be  executed  in one or more
counterparts,  each of which when so executed  shall be deemed to be an original
but all of  which  when  taken  together  shall  constitute  one  and  the  same
instrument.  In making  proof of this  Amendment,  it shall not be  necessary to
produce or account for more than one  counterpart  hereof  signed by each of the
parties hereto.  This Amendment may be executed and delivered by telecopier with
the same  force  and  effect as if it were a  manually  executed  and  delivered
counterpart.

                                    SAFETY COMPONENTS FABRIC
                                    TECHNOLOGIES, INC.

                                    By:____________________________

                                    Title:_________________________

                                    AUTOMOTIVE SAFETY COMPONENTS
                                    INTERNATIONAL, INC.

                                    By:____________________________

                                    Title:_________________________

                                    AUTOMOTIVE SAFETY COMPONENTS
                                    INTERNATIONAL GmbH & Co. KG

                                    By:____________________________

                                    Title:_________________________

                                    AUTOMOTIVE SAFETY COMPONENTS
                                    INTERNATIONAL LIMITED

                                    By:____________________________

                                    Title:_________________________

                                    VALENTEC WELLS, LLC (formerly known
                                    as Valentec International Corporation, LLC)

                                    By:____________________________

                                    Title:_________________________

                                    SAFETY COMPONENTS INTERNATIONAL, INC.

                                    By:____________________________

                                    Title:_________________________

                       [SIGNATURES CONTINUE ON NEXT PAGE]

                                       6
<PAGE>

                                    ASCI HOLDINGS GERMANY (DE), INC.

                                    By:____________________________

                                    Title:_________________________

                                    ASCI HOLDINGS U.K. (DE), INC.

                                    By:____________________________

                                    Title:_________________________

                                    ASCI HOLDINGS MEXICO (DE), INC.

                                    By:____________________________

                                    Title:_________________________

                                    ASCI HOLDINGS CZECH (DE), INC.

                                    By:____________________________

                                    Title:_________________________

                                    AUTOMOTIVE SAFETY COMPONENTS
                                    INTERNATIONAL, S.A. de C.V.

                                    By:____________________________

                                    Title:_________________________

                                    AUTOMOTIVE SAFETY COMPONENTS
                                    INTERNATIONAL S.R.O.

                                    By:____________________________

                                    Title:_________________________

AGREED:

CONGRESS FINANCIAL CORPORATION
(SOUTHERN)

By: _________________________________

Title: ______________________________

                                       7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}]]